N-Q 1 fundsoi.htm PIONEER FUND SOI fundsoi.htm
                                                             OMB APPROVAL
                                                     OMB Number:       3235-0578
                                                     Expires:  January 31, 2016
                                                     Estimated average burden
                                                     hours per response.....
                                                     10.5

                                 UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM N-Q

                   QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS
    OF REGISTERED MANAGEMENT INVESTMENT COMPANY



  Investment Company Act file number 811-01466


                         Pioneer Fund
               (Exact name of registrant as specified in charter)


                       60 State Street, Boston, MA 02109
              (Address of principal executive offices) (ZIP code)


            Terrence J. Cullen, Pioneer Investment Management, Inc.,
                       60 State Street, Boston, MA 02109
                    (Name and address of agent for service)


Registrant's telephone number, including area code:  (617) 742-7825


Date of fiscal year end:  December 31

Date of reporting period:  March 31, 2015

Form N-Q is to be used by management investment companies, other than small
business investment companies registered on Form N-5 (239.24 and 274.5 of this
chapter), to file reports with the Commission, not later than 60 days after
close of the first and third fiscal quarters, pursuant to Rule 30b1-5 under
the Investment Company Act of 1940 (17 CFR 270.30b1-5).  The Commission may
use the information provided on Form N-Q in its regulatory, disclosure review,
inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-Q,
and the Commission will make this information public. A registrant is not
required to respond to the collection of information contained in Form N-Q
unless the Form displays a currently valid Office of Management and Budget
("OMB") control number. Please direct comments concerning the accuracy of the
information collection burden estimate and any suggestions for reducing the
burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW,
Washington, DC 20549-0609.  The OMB has reviewed this collection of information
under the clearance requirements of 44 U.S.C. ss. 3507.


<PAGE>
ITEM 1. Schedule of Investments.

File the schedules as of the close of the reporting period as set forth in
ss. 210.12-12  12-14 of Regulation S-X [17 CFR 210.12-12  12-14]. The
schedules need not be audited.





       
Pioneer Fund
         
       
Schedule of Investments 3/31/15
         
                   
 
Shares
       
Value
     
       
COMMON STOCKS - 100.0%
         
       
Energy - 6.1%
         
       
Oil & Gas Drilling - 0.2%
         
 
182,538
   
Helmerich & Payne, Inc.
$
12,425,362
     
       
Oil & Gas Equipment & Services - 0.3%
         
 
376,594
   
Cameron International Corp. *
$
16,991,921
     
       
Integrated Oil & Gas - 0.3%
         
 
242,670
   
Occidental Petroleum Corp.
$
17,714,910
     
       
Oil & Gas Exploration & Production - 3.2%
         
 
563,863
   
Apache Corp.
$
34,017,855
     
 
1,400,229
   
Cabot Oil & Gas Corp.
 
41,348,762
     
 
549,378
   
ConocoPhillips
 
34,204,274
     
 
1,206,974
   
Marathon Oil Corp.
 
31,514,091
     
 
1,170,746
   
Southwestern Energy Co. *
 
27,149,600
     
         
$
168,234,582
     
       
Oil & Gas Refining & Marketing - 1.5%
         
 
406,740
   
Marathon Petroleum Corp.
$
41,646,109
     
 
438,706
   
Phillips 66
 
34,482,292
     
         
$
76,128,401
     
       
Oil & Gas Storage & Transportation - 0.6%
         
 
689,204
   
Kinder Morgan, Inc./DE
$
28,987,920
     
       
Total Energy
$
320,483,096
     
       
Materials - 3.6%
         
       
Diversified Chemicals - 1.1%
         
 
290,130
   
EI du Pont de Nemours & Co.
$
20,735,591
     
 
742,486
   
The Dow Chemical Co.
 
35,624,478
     
         
$
56,360,069
     
       
Fertilizers & Agricultural Chemicals - 0.4%
         
 
192,778
   
Monsanto Co.
$
21,695,236
     
       
Specialty Chemicals - 2.1%
         
 
504,292
   
Ecolab, Inc.
$
57,680,919
     
 
9,886
   
Givaudan SA
 
17,913,546
     
 
435,751
   
The Valspar Corp.
 
36,616,157
     
         
$
112,210,622
     
       
Total Materials
$
190,265,927
     
       
Capital Goods - 7.7%
         
       
Aerospace & Defense - 2.1%
         
 
217,648
   
Honeywell International, Inc.
$
22,702,863
     
 
744,216
   
United Technologies Corp.
 
87,222,115
     
         
$
109,924,978
     
       
Building Products - 0.6%
         
 
334,340
   
Allegion Plc
$
20,451,578
     
 
246,689
   
Fortune Brands Home & Security, Inc.
 
11,712,794
     
         
$
32,164,372
     
       
Electrical Components & Equipment - 0.8%
         
 
308,563
   
Eaton Corp. Plc
$
20,963,770
     
 
164,875
   
Rockwell Automation, Inc.
 
19,123,851
     
         
$
40,087,621
     
       
Industrial Conglomerates - 2.4%
         
 
399,857
   
3M Co.
$
65,956,412
     
 
2,447,219
   
General Electric Co.
 
60,715,503
     
         
$
126,671,915
     
       
Construction & Farm Machinery & Heavy Trucks - 0.8%
         
 
131,912
   
Cummins, Inc.
$
18,288,280
     
 
386,763
   
PACCAR, Inc.
 
24,420,216
     
         
$
42,708,496
     
       
Industrial Machinery - 1.0%
         
 
767,254
   
Ingersoll-Rand Plc
$
52,234,652
     
       
Total Capital Goods
$
403,792,034
     
       
Transportation - 2.0%
         
       
Railroads - 2.0%
         
 
456,660
   
Norfolk Southern Corp.
$
46,999,447
     
 
523,748
   
Union Pacific Corp.
 
56,727,146
     
         
$
103,726,593
     
       
Total Transportation
$
103,726,593
     
       
Automobiles & Components - 0.6%
         
       
Auto Parts & Equipment - 0.6%
         
 
509,533
   
BorgWarner, Inc.
$
30,816,556
     
       
Total Automobiles & Components
$
30,816,556
     
       
Consumer Durables & Apparel - 1.1%
         
       
Household Appliances - 1.1%
         
 
988,608
   
Electrolux AB
$
28,334,365
     
 
137,465
   
Whirlpool Corp.
 
27,776,178
     
         
$
56,110,543
     
       
Total Consumer Durables & Apparel
$
56,110,543
     
       
Consumer Services - 0.1%
         
       
Education Services - 0.1%
         
 
197,722
   
Houghton Mifflin Harcourt Co. *
$
4,642,513
     
       
Total Consumer Services
$
4,642,513
     
       
Media - 7.5%
         
       
Broadcasting - 1.6%
         
 
548,711
   
CBS Corp. (Class B)
$
33,268,348
     
 
751,625
   
Scripps Networks Interactive, Inc.
 
51,531,410
     
         
$
84,799,758
     
       
Movies & Entertainment - 2.2%
         
 
850,783
   
The Walt Disney Co.
$
89,238,629
     
 
313,543
   
Time Warner, Inc.
 
26,475,571
     
         
$
115,714,200
     
       
Publishing - 3.7%
         
 
493,699
   
Gannett Co, Inc.
$
18,306,359
     
 
2,736,229
   
John Wiley & Sons, Inc. (Class A) +
 
167,293,039
     
 
252,541
   
Time, Inc.
 
5,667,020
     
         
$
191,266,418
     
       
Total Media
$
391,780,376
     
       
Retailing - 5.2%
         
       
Department Stores - 1.6%
         
 
727,690
   
Macy's, Inc.
$
47,234,358
     
 
463,524
   
Nordstrom, Inc.
 
37,230,248
     
         
$
84,464,606
     
       
Apparel Retail - 2.8%
         
 
745,883
   
Ross Stores, Inc.
$
78,586,233
     
 
953,610
   
The TJX Companies, Inc.
 
66,800,380
     
         
$
145,386,613
     
       
Home Improvement Retail - 0.8%
         
 
357,975
   
The Home Depot, Inc.
$
40,669,540
     
       
Total Retailing
$
270,520,759
     
       
Food & Staples Retailing - 2.1%
         
       
Drug Retail - 2.1%
         
 
1,072,567
   
CVS Health Corp.
$
110,699,640
     
       
Total Food & Staples Retailing
$
110,699,640
     
       
Food, Beverage & Tobacco - 8.7%
         
       
Soft Drinks - 2.4%
         
 
1,008,042
   
Coca-Cola Enterprises, Inc.
$
44,555,456
     
 
392,823
   
Dr. Pepper Snapple Group, Inc.
 
30,828,749
     
 
1,246,636
   
The Coca-Cola Co.
 
50,551,090
     
         
$
125,935,295
     
       
Packaged Foods & Meats - 6.3%
         
 
930,715
   
Campbell Soup Co.
$
43,324,783
     
 
546,687
   
General Mills, Inc.
 
30,942,484
     
 
395,823
   
Kraft Foods Group, Inc.
 
34,482,121
     
 
463,191
   
Mead Johnson Nutrition Co.
 
46,564,591
     
 
1,476,964
   
Mondelez International, Inc.
 
53,303,631
     
 
1,176,506
   
The Hershey Co.
 
118,721,220
     
         
$
327,338,830
     
       
Total Food, Beverage & Tobacco
$
453,274,125
     
       
Household & Personal Products - 0.5%
         
       
Household Products - 0.5%
         
 
228,671
   
The Clorox Co.
$
25,242,992
     
       
Total Household & Personal Products
$
25,242,992
     
       
Health Care Equipment & Services - 8.8%
         
       
Health Care Equipment - 5.0%
         
 
1,112,248
   
Abbott Laboratories
$
51,530,450
     
 
449,863
   
Becton Dickinson and Co.
 
64,595,828
     
 
664,027
   
CR Bard, Inc.
 
111,124,918
     
 
1,824,807
   
Smith & Nephew Plc
 
30,992,200
     
         
$
258,243,396
     
       
Health Care Distributors - 1.9%
         
 
362,274
   
Cardinal Health, Inc.
$
32,702,474
     
 
303,690
   
McKesson Corp.
 
68,694,678
     
         
$
101,397,152
     
       
Health Care Services - 0.4%
         
 
259,702
   
Express Scripts Holding Co. *
$
22,534,343
     
       
Managed Health Care - 1.5%
         
 
459,084
   
Aetna, Inc.
$
48,906,219
     
 
155,845
   
Humana, Inc.
 
27,743,527
     
         
$
76,649,746
     
       
Total Health Care Equipment & Services
$
458,824,637
     
       
Pharmaceuticals, Biotechnology & Life Sciences - 11.9%
         
       
Biotechnology - 2.1%
         
 
331,620
   
Alnylam Pharmaceuticals, Inc. *
$
34,627,760
     
 
641,055
   
Celgene Corp. *
 
73,900,820
     
         
$
108,528,580
     
       
Pharmaceuticals - 8.7%
         
 
676,326
   
AbbVie, Inc.
$
39,592,124
     
 
366,397
   
AstraZeneca Plc (A.D.R.)
 
25,072,547
     
 
364,715
   
Eli Lilly & Co.
 
26,496,545
     
 
560,177
   
GlaxoSmithKline Plc (A.D.R.)
 
25,852,169
     
 
806,434
   
Johnson & Johnson
 
81,127,260
     
 
319,137
   
Mallinckrodt Plc *
 
40,418,701
     
 
812,652
   
Merck & Co., Inc.
 
46,711,237
     
 
888,448
   
Pfizer, Inc.
 
30,909,106
     
 
73,989
   
Roche Holding AG
 
20,399,476
     
 
395,443
   
Shire Plc
 
31,496,556
     
 
1,853,184
   
Zoetis, Inc.
 
85,783,887
     
         
$
453,859,608
     
       
Life Sciences Tools & Services - 1.1%
         
 
426,090
   
Thermo Fisher Scientific, Inc.
$
57,240,931
     
       
Total Pharmaceuticals, Biotechnology & Life Sciences
$
619,629,119
     
       
Banks - 8.0%
         
       
Diversified Banks - 5.6%
         
 
3,230,169
   
Bank of America Corp.
$
49,712,301
     
 
643,019
   
Citigroup, Inc.
 
33,128,339
     
 
1,601,885
   
US Bancorp/MN
 
69,954,318
     
 
2,598,318
   
Wells Fargo & Co.
 
141,348,499
     
         
$
294,143,457
     
       
Regional Banks - 2.4%
         
 
976,432
   
BB&T Corp.
$
38,071,084
     
 
285,055
   
Citizens Financial Group, Inc.
 
6,878,377
     
 
866,429
   
The PNC Financial Services Group, Inc.
 
80,785,840
     
         
$
125,735,301
     
       
Total Banks
$
419,878,758
     
       
Diversified Financials - 5.5%
         
       
Consumer Finance - 2.0%
         
 
879,633
   
American Express Co.
$
68,716,930
     
 
668,962
   
Discover Financial Services, Inc.
 
37,696,009
     
         
$
106,412,939
     
       
Asset Management & Custody Banks - 1.9%
         
 
698,337
   
Franklin Resources, Inc.
$
35,838,655
     
 
713,112
   
Invesco, Ltd.
 
28,303,415
     
 
464,270
   
State Street Corp.
 
34,137,773
     
         
$
98,279,843
     
       
Investment Banking & Brokerage - 1.6%
         
 
1,407,142
   
Morgan Stanley Co.
$
50,220,898
     
 
1,081,989
   
The Charles Schwab Corp.
 
32,935,745
     
         
$
83,156,643
     
       
Total Diversified Financials
$
287,849,425
     
       
Insurance - 2.8%
         
       
Property & Casualty Insurance - 2.8%
         
 
933,138
   
The Chubb Corp.
$
94,340,252
     
 
452,398
   
The Travelers Companies, Inc.
 
48,917,796
     
         
$
143,258,048
     
       
Total Insurance
$
143,258,048
     
       
Real Estate - 0.1%
         
       
Specialized REIT - 0.1%
         
 
111,463
   
Outfront Media, Inc.
$
3,334,973
     
       
Total Real Estate
$
3,334,973
     
       
Software & Services - 9.7%
         
       
Internet Software & Services - 3.2%
         
 
486,981
   
eBay, Inc. *
$
28,089,064
     
 
701,962
   
Facebook, Inc. *
 
57,711,806
     
 
94,187
   
Google, Inc. (Class A) *
 
52,245,529
     
 
49,130
   
Google, Inc. (Class C)
 
26,923,240
     
         
$
164,969,639
     
       
IT Consulting & Other Services - 0.4%
         
 
132,583
   
International Business Machines Corp.
$
21,279,572
     
       
Data Processing & Outsourced Services - 2.9%
         
 
456,944
   
Automatic Data Processing, Inc.
$
39,132,684
     
 
337,469
   
DST Systems, Inc.
 
37,361,193
     
 
620,487
   
Fiserv, Inc. *
 
49,266,668
     
 
389,732
   
Visa, Inc.
 
25,492,370
     
         
$
151,252,915
     
       
Application Software - 0.1%
         
 
127,726
   
CDK Global, Inc.
$
5,972,468
     
       
Systems Software - 3.1%
         
 
320,360
   
Check Point Software Technologies, Ltd. *
$
26,259,909
     
 
2,882,677
   
Microsoft Corp.
 
117,195,233
     
 
878,052
   
Symantec Corp.
 
20,515,685
     
         
$
163,970,827
     
       
Total Software & Services
$
507,445,421
     
       
Technology Hardware & Equipment - 5.1%
         
       
Communications Equipment - 0.9%
         
 
392,255
   
F5 Networks, Inc. *
$
45,085,790
     
       
Computer Storage & Peripherals - 3.7%
         
 
1,150,874
   
Apple, Inc.
$
143,203,252
     
 
2,047,817
   
EMC Corp.
 
52,342,203
     
         
$
195,545,455
     
       
Technology Hardware, Storage & Peripherals - 0.5%
         
 
778,892
   
NetApp, Inc.
$
27,619,510
     
       
Total Technology Hardware & Equipment
$
268,250,755
     
       
Semiconductors & Semiconductor Equipment - 1.4%
         
       
Semiconductor Equipment - 0.5%
         
 
261,975
   
ASML Holding NV (A.D.R.)
$
26,467,334
     
       
Semiconductors - 0.9%
         
 
764,777
   
Analog Devices, Inc.
$
48,180,951
     
       
Total Semiconductors & Semiconductor Equipment
$
74,648,285
     
       
Utilities - 1.5%
         
       
Electric Utilities - 1.5%
         
 
761,567
   
American Electric Power Co., Inc.
$
42,838,144
     
 
323,214
   
NextEra Energy, Inc.
 
33,630,417
     
         
$
76,468,561
     
       
Total Utilities
$
76,468,561
     
       
TOTAL COMMON STOCKS
         
       
(Cost $3,118,681,449)
$
5,220,943,136
     
                   
       
TOTAL INVESTMENT IN SECURITIES - 100.0%
         
       
(Cost $3,118,681,449) (a)
$
5,220,943,136
     
                   
       
OTHER ASSETS & LIABILITIES - 0.0%
$
2,333,521
     
                   
       
TOTAL NET ASSETS - 100.0%
$
5,223,276,657
     
                   
 
*
   
Non-income producing security.
         
                   
 
+
   
Investment held by the Fund representing 5% or more of the outstanding voting stock of such company.
       
                   
 
(A.D.R.)
   
American Depositary Receipts.
         
                   
 
REIT
   
Real Estate Investment Trust.
         
                   
 
(a)
   
At March 31, 2015, the net unrealized appreciation on investments based on
         
       
cost for federal income tax purposes of $3,118,681,449 was as follows:
         
                   
       
Aggregate gross unrealized appreciation for all investments in which
         
       
there is an excess of value over tax cost
$
         2,157,051,215
     
                   
       
Aggregate gross unrealized depreciation for all investments in which
         
       
there is an excess of tax cost over value
 
            (54,789,528)
     
                   
       
Net unrealized appreciation
$
         2,102,261,687
     
                   
Various inputs are used in determining the value of the Fund's investments.  These inputs are summarized in the three broad levels listed below.
     
                   
Level 1 – quoted prices in active markets for identical securities
         
Level 2 – other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.)  See Notes to Financial Statements — Note 1A.
Level 3 – significant unobservable inputs (including the Fund's own assumptions in determining fair value of investments)  See Notes to Financial Statements — Note 1A.
                   
Generally, equity securities are categorized as Level 1, fixed income securities and senior loans as Level 2 and securities valued
         
using fair value methods (other than prices supplied by independent pricing services or broker-dealers) as Level 3.
         
                   
The following is a summary of the inputs used as of March 31, 2015, in valuing the Fund's investments:
         
                   



   
Level 1
   
Level 2
   
Level 3
   
Total
 
Common Stocks
  $ 5,220,943,136     $ -     $ -     $ 5,220,943,136  
Total
  $ 5,220,943,136     $ -     $ -     $ 5,220,943,136  
                                 
During the period ended March 31, 2015, there were no transfers between Levels 1, 2 and 3.
                               



ITEM 2. CONTROLS AND PROCEDURES. (a) Disclose the conclusions of the registrant's principal executive and principal financial officers, or persons performing similar functions, regarding the effectiveness of the registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Act (17 CFR 270.30a-3(c))) as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the Act (17 CFR 270.30a-3(b))) and Rule 13a-15(b) or 15d-15(b) under the Exchange Act (17 CFR 240.13a-15(b) or 240.15d-15(b)). The registrant's principal executive officer and principal financial officer have concluded that the registrant's disclosure controls and procedures are effective based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report. (b) Disclose any change in the registrant's internal controls over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d)) that occurred during the registrant's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting. There were no significant changes in the registrant's internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant's internal control over financial reporting. ITEM 3. EXHIBITS. File as exhibits as part of this Form a separate certification for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)), exactly as set forth below: CERTIFICATIONS I, [identify the certifying individual], certify that: 1. I have reviewed this report on Form N-Q of [identify registrant]; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed; 4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and (d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and 5. The registrants other certifying officer(s) and I have disclosed to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize, and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. Date: [Signature] [Title] Filed herewith. <PAGE> SIGNATURES [See General Instruction F] Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. (Registrant) Pioneer Fund By (Signature and Title)* /s/ Lisa M.Jones ----------------------- Lisa M.Jones, President and Chief Executive Officer Date May 29, 2015 Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. By (Signature and Title)* /s/ Lisa M.Jones ----------------------- Lisa M.Jones, President and Chief Executive Officer Date May 29, 2015 By (Signature and Title)* /s/ Mark E. Bradley ----------------- Mark E. Bradley, Treasurer and Chief Accounting and Financial Officer Date May 29, 2015 * Print the name and title of each signing officer under his or her signature.